ArticleNeuro-oncology advances

Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer.

Jana Ivanidze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.